Short-Term Side Effects of Low Dose Valproate Monotherapy in Epileptic Children: A Prospective Study.

Iran J Child Neurol

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Published: January 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: Considering the common use of valproate among children, we investigated the short-term side-effects of low dose valproate monotherapy in epileptic children.

Materials & Methods: In this prospective study, 209 epileptic children (48.3% male, mean age: 7.02 ± 3.13 yr) on low therapeutic dose of valproate monotherapy (20-30 mg/kg/d) were enrolled during 2014-2015 in Isfahan Pediatric Neurology Clinic, Isfahan University of Medical Sciences, Isfahan, Iran and side-effects were evaluated through frequent clinical visits and laboratory tests during 6 months of valproate therapy.

Results: Weight gain was reported in 53.1% of patients. Decreased appetite was seen in 11% of patients, more frequent in younger cases (=0.006). Abdominal pain, nausea/vomiting, diarrhea, and constipation were reported in 16.3%, 2.4%, 1.4%, and 1% of patients, respectively. Headache, tremor, dizziness, abnormal color vision, myoclonus, and bruxism were seen in 5.7%, 1.4%, 1%, 1%, 1%, and 0.5% of patients, respectively. Enuresis, hair loss, and skin rash were reported in 8.1%, 6.7%, and 0.5% of patients, respectively. Thrombocytopenia, impaired liver function tests, and leukopenia occurred in 1%, 1%, and 0.5% of patients, respectively.

Conclusion: Low dose valproate monotherapy may cause numerous side-effects, mostly not life-threatening and requiring no action. Besides more reported complications, we observed decreased appetite (among younger patients), enuresis, and abnormal color vision which are onlybriefly discussed in the literature and need to be addressed more.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451855PMC

Publication Analysis

Top Keywords

dose valproate
16
valproate monotherapy
16
low dose
12
05% patients
12
monotherapy epileptic
8
epileptic children
8
prospective study
8
decreased appetite
8
abnormal color
8
color vision
8

Similar Publications

Zebrafish embryos are widely used in developmental toxicity testing. However, the extent to which genetic background influences susceptibility to teratogenic compounds remains incompletely understood. We here evaluated inter-strain variability in both phenotypic and transcriptomic responses to six model teratogens using five commonly utilized zebrafish strains, AB, TU, RW, WIK, and PET.

View Article and Find Full Text PDF

Mouse Model of Prenatal Valproic Acid Exposure: Effects on Cortical Morphogenesis and Behavioral Outcomes Across Environmental Conditions.

Toxicol Lett

September 2025

Mammalian Embryology, Department of Life Science, Faculty of Science and Engineering, Kindai University 3-4-1, Kowake, Higashiosaka, Osaka 577-8501, Japan. Electronic address:

Autism spectrum disorder (ASD) is a developmental disability characterized by impaired social communication and repetitive behaviors, and environmental and genetic factors are involved in its onset. The use of the antiepileptic drug valproic acid (VPA) during pregnancy is associated with neural tube defects and developmental disorders in the fetus. In this study, we aimed to identify abnormalities in cortical morphogenesis owing to prenatal VPA exposure and to elucidate the abnormalities in brain function associated with these abnormalities, particularly by comparing multiple and single environments.

View Article and Find Full Text PDF

Introduction: Inflammation and oxidative stress are considered main pathophysiological factors for neuronal and cardiovascular diseases, also leading to the impairment of main cellular metabolic pathways. Promotion of hyperlipidemia is also the result of inflammatory and oxidative (ROS production) processes. Additionally, compounds of medicinal interest like valproic and caffeic acids and amino acids like proline and tyrosine have shown antiinflammatory and cellular protective potency.

View Article and Find Full Text PDF

Objective: Folic acid supplementation is recommended by WHO for all pregnancies to reduce the risk of neural tube defects and improve neurodevelopmental outcomes. No study to date directly compares the effects on children's outcomes for different folic acid dosages taken by pregnant people with epilepsy. Thus, the optimal folic acid dosing remains unclear, with current guidelines recommending a wide range of doses (.

View Article and Find Full Text PDF

Pre- and Postnatal Valproate Exposure Affects Brain Development.

Curr Top Behav Neurosci

August 2025

Behavioural Neurogenetics Laboratory, School of Psychology, Te Herenga Waka - Victoria University of Wellington, Wellington, New Zealand.

This review investigates the teratogenic impact of valproic acid (VPA) on brain development, focusing on dose-dependent and timing-related behavioural and neurological outcomes in rats and mice, with an emphasis on using it as a model for autism spectrum disorders (ASD). Single and multiple administration methods (e.g.

View Article and Find Full Text PDF